Skip to main content

Table 4 Total cost and effectiveness in each group; from the point of view of the health insurance and the care producer

From: Effectiveness and cost-effectiveness of a telemedicine programme for preventing unplanned hospitalisations of older adults living in nursing homes: the GERONTACCESS cluster randomized clinical trial

 

Intervention group

N = 214

Control group

N = 212

Difference

(Δ)

p value

COST ($)

 From the perspective of health insurance

  Total cost 1 mean ± (SD)

1,900 (± 3,040)

2,250 (± 3,450)

- 350

0.274

 From the perspective of the care producer

  Total cost 2 mean ± (SD)

2,290 (± 4,600)

2,470 (± 4,120)

- 180

0.662

EFFECTIVENESS

 The proportion of patients with unplanned hospitalization

0.234

0.325

0.091

0.034

ICER 1 (ΔC1/ ΔE) = 

-3,846

ICER 2 (ΔC2/ ΔE) = 

-1,978